The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines after a safety concern was found to be unrelated ...
Novavax (NASDAQ:NVAX) shares climbed 12% premarket on Monday after the U.S. FDA lifted clinical hold on the investigational new drug application for the pharma firm’s COVID-19-Influenza ...
(RTTNews) - Novavax, Inc. (NVAX) Monday said the Food and Drug Administration or FDA has removed the clinical hold on its COVID-19-Influenza Combination (CIC) and stand-alone influenza vaccine ...
Novavax received clearance from the FDA to move forward with phase 3 clinical trials for its COVID-19-influenza ... to the investigational vaccine. With the clinical hold now lifted, Novavax ...
Novavax can move forward with a trial for its combined Covid-19 and influenza vaccine after regulators lifted a clinical hold ... plans to file for FDA approval of its own combo vaccine by ...
announced that the U.S. FDA has removed the clinical hold on Novavax’s Investigational New Drug application for its COVID-19-Influenza Combination and stand-alone influenza vaccine candidates.
The clinical hold lift comes less than three months after Novavax’s JN.1-adapted COVID-19 vaccine was granted emergency use authorisation by the FDA for use in individuals aged 12 years and older. The ...
Novavax will be working with the clinical trial investigators and other partners to resume trial activities as quickly as possible. In October, the FDA issued the clinical hold due to a ...
(Reuters) -The U.S. Food and Drug Administration has lifted its clinical hold on ... combination shot and flu vaccine to ...
Novavax can move forward with a trial for its combined Covid-19 ... the clinical hold on its investigational new drug application for its combined vaccine and its standalone flu vaccine candidates.
The US Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu ... shot, the company said. "The information provided to ...